ResearcherAmsterdam University Medical CentersActive in the last 2 years

Mafalda Angelica Rocco

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-5410-8841; OpenAlex author ID A5104348818. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2026: 2 papers

Papers 2

CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2026.218851 ↗
The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance. First author DOI 10.1016/j.drup.2026.101408 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elisa Giovannetti · 2 shared papers, 2026 · strength 0.67
- Paper CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. DOI 10.1016/j.canlet.2026.218851 ↗
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408 ↗
Mahrou Vahabi · 1 shared paper, 2026 · strength 0.33
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408 ↗
Benoît Immordino · 1 shared paper, 2026 · strength 0.33
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408 ↗
Annalisa Comandatore · 1 shared paper, 2026 · strength 0.33
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408 ↗
Liam Andrew McDonnell · 1 shared paper, 2026 · strength 0.33
- Paper CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. DOI 10.1016/j.canlet.2026.218851 ↗
Giulia Lencioni · 1 shared paper, 2026 · strength 0.33
- Paper CRISPR-based diagnostics as a specificity layer for the early detection of pancreatic cancer. DOI 10.1016/j.canlet.2026.218851 ↗
Luca Morelli · 1 shared paper, 2026 · strength 0.33
- Paper The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resista… DOI 10.1016/j.drup.2026.101408 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.